Trans Genic Inc.

38
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3635720000
JPY
265.00
-7 (-2.57%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Trans Genic Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-675.00
43.00
-331.00
2,767.00
695.00
-249.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
253.00
-659.00
-958.00
-47.00
180.00
-91.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
94.00
-392.00
-1,430.00
1,789.00
1,222.00
-20.00
Cash Flow from Investing Activities
-287.00
-280.00
-216.00
981.00
48.00
-318.00
Cash Flow from Financing Activities
265.00
-342.00
484.00
-1,183.00
10.00
666.00
Net Cash Inflow / Outflow
75.00
-993.00
-1,159.00
1,588.00
1,280.00
325.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
4.00
22.00
1.00
0.00
0.00
-1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Trans Genic Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Profit Before Tax
-675.959
72.867
-747.00
-1027.66%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
253.288
897.505
-644.00
-71.78%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
94.096
936.707
-842.00
-89.95%
Cash Flow from Investing Activities
-287.846
65.077
-352.00
-542.32%
Cash Flow from Financing Activities
265.098
-240.061
505.00
210.43%
Net Cash Inflow / Outflow
75.635
764.022
-689.00
-90.10%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
4.287
2.299
2.00
86.47%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
stock-summary

YoY Growth in year ended Mar 2025 is 123.98% vs 72.56% in Mar 2024

Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
94.10
-392.45
123.98%